These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 11748735)
1. Gastric emptying time and gastric motility in patients with Parkinson's disease. Hardoff R; Sula M; Tamir A; Soil A; Front A; Badarna S; Honigman S; Giladi N Mov Disord; 2001 Nov; 16(6):1041-7. PubMed ID: 11748735 [TBL] [Abstract][Full Text] [Related]
2. Delayed Gastric Emptying in Advanced Parkinson Disease: Correlation With Therapeutic Doses. Bestetti A; Capozza A; Lacerenza M; Manfredi L; Mancini F Clin Nucl Med; 2017 Feb; 42(2):83-87. PubMed ID: 27941374 [TBL] [Abstract][Full Text] [Related]
3. Unchanged gastric emptying and visceral perception in early Parkinson's disease after a high caloric test meal. Epprecht L; Schreglmann SR; Goetze O; Woitalla D; Baumann CR; Waldvogel D J Neurol; 2015 Aug; 262(8):1946-53. PubMed ID: 26048686 [TBL] [Abstract][Full Text] [Related]
4. Is there a difference in gastric emptying between Parkinson's disease patients under long-term L-dopa therapy with and without motor fluctuations? An analysis using the 13C-acetate breath test. Tanaka Y; Kato T; Nishida H; Araki H; Murase M; Nagaki M; Moriwaki H; Inuzuka T J Neurol; 2009 Dec; 256(12):1972-6. PubMed ID: 19575260 [TBL] [Abstract][Full Text] [Related]
5. Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's disease. Asai H; Udaka F; Hirano M; Minami T; Oda M; Kubori T; Nishinaka K; Kameyama M; Ueno S Parkinsonism Relat Disord; 2005 Dec; 11(8):499-502. PubMed ID: 16263322 [TBL] [Abstract][Full Text] [Related]
6. Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease. Doi H; Sakakibara R; Sato M; Masaka T; Kishi M; Tateno A; Tateno F; Tsuyusaki Y; Takahashi O J Neurol Sci; 2012 Aug; 319(1-2):86-8. PubMed ID: 22632782 [TBL] [Abstract][Full Text] [Related]
7. Gastric emptying in Parkinson's disease: patients with and without response fluctuations. Djaldetti R; Baron J; Ziv I; Melamed E Neurology; 1996 Apr; 46(4):1051-4. PubMed ID: 8780089 [TBL] [Abstract][Full Text] [Related]
8. [Gastrointestinal dysfunction has important implications for plasma L-dopa concentrations in Parkinson's disease]. Doi H; Sakakibara R; Kishi M; Tsuyuzaki Y; Tateno F; Hirai S Rinsho Shinkeigaku; 2013; 53(11):1382-5. PubMed ID: 24291998 [TBL] [Abstract][Full Text] [Related]
9. Electrogastrographyc activity in Parkinson's disease patients with and without motor fluctuations. Albani G; El Assawy N; Cattaldo S; De Gennaro M; Gregorini F; Pradotto L; Mauro A Mov Disord; 2011 Aug; 26(9):1737-40. PubMed ID: 21618609 [TBL] [Abstract][Full Text] [Related]
10. Irregular gastrointestinal drug absorption in Parkinson's disease. Nyholm D; Lennernäs H Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):193-203. PubMed ID: 18248312 [TBL] [Abstract][Full Text] [Related]
11. Impaired gastric emptying of a solid test meal in patients with Parkinson's disease using 13C-sodium octanoate breath test. Goetze O; Wieczorek J; Mueller T; Przuntek H; Schmidt WE; Woitalla D Neurosci Lett; 2005 Mar; 375(3):170-3. PubMed ID: 15694254 [TBL] [Abstract][Full Text] [Related]
12. Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients. Müller T; Erdmann C; Bremen D; Schmidt WE; Muhlack S; Woitalla D; Goetze O Clin Neuropharmacol; 2006; 29(2):61-7. PubMed ID: 16614536 [TBL] [Abstract][Full Text] [Related]
13. Clinical implications of gastric complications on levodopa treatment in Parkinson's disease. Pfeiffer RF; Isaacson SH; Pahwa R Parkinsonism Relat Disord; 2020 Jul; 76():63-71. PubMed ID: 32461054 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease. Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409 [TBL] [Abstract][Full Text] [Related]
15. Gastric emptying after semi-solid food in multiple system atrophy and Parkinson disease. Thomaides T; Karapanayiotides T; Zoukos Y; Haeropoulos C; Kerezoudi E; Demacopoulos N; Floodas G; Papageorgiou E; Armakola F; Thomopoulos Y; Zaloni I J Neurol; 2005 Sep; 252(9):1055-9. PubMed ID: 15795792 [TBL] [Abstract][Full Text] [Related]